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Background: In patients with acute stroke and middle 
cerebral artery (MCA) stenosis, microembolic signals (MES) 
can predict further cerebral ischemia. Therefore, this study 
was designed to evaluate the prevalence of MES by 
transcranial Doppler (TCD) in patients with MCA stenosis 
under treatment of aspirin or clopidogrel. 
Methods: A randomized clinical trial was performed on 40 
patients with acute ischemic stroke in MCA territory. They 
were randomly allocated in two groups that treated with 
aspirin (80 mg daily) or clopidogrel (75 mg daily). Clinical 
and diagnostic work up was included evaluation of 
cerebrovascular risk factors, echocardiography, carotid color 
Doppler and brain imaging. TCD was performed between 
day 3 and 7 after symptoms onset to detect MES. All high 
intensity transient signals (HITS) were saved and analyzed 
offline. 
Results: Carotid stenosis was found in 13 (65%) patients of 
aspirin group and 12 (60%) of clopidogrel group. Four 
(30.8%) of aspirin group and 5 (41.7) of clopidogrel group 
had stenosis between 10%-50%. One patient in each group 
had more than 50% stenosis and the remainder had less 
than 10%. There was no signi:cant di;erence between two 
groups. MES was detected in 6 (30%) of patients treated 
with aspirin and 4 (20%) of those treated with 
clopidogrel. It showed no statistically significant 
differences (P-value= 0.46). 
Conclusion: Our results indicate a similar effect of 
aspirin and clopidogrel on frequency of MES in patients 
with MCA territory ischemic stroke. 
Introduction 
Atherosclerotic stenosis of cerebral vessels is a common 
cause of stroke and death worldwide [1]. Over 80% of all 
stroke deaths in the world occur in the developing 
countries [2]. The risk of early recurrent stroke in patients 
with minor strokes or transient ischemic attacks might be 
as high as 8-12% in the first 7 days [3]. Intracranial 
stenosis also has a high early risk of recurrent stroke 
which decreases over time. In patients with intracranial 
stenosis, that endarterectomy is not possible like cervical 
carotid stenosis; antiplatelet therapy has been 
recommended [1]. In patients with intracranial stenosis, 
the presence of microembolic signal (MES) is associated. 
with increased risk of early recurrent transient ischemic 
attack, stroke [5-7] and new silent cerebral infarcts [8]. In 
acute stroke patients with middle cerebral artery  (MCA) 
stenosis, MES predicts further cerebral ischemia [9]. 
In recent years transcranial Doppler (TCD) was used to 
detect MES successfully. Considering the routine 
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in patients with middle cerebral artery stenosis, we conducted 
this study to evaluate the prevalence of MES by TCD in 
patients under treatment with aspirin or clopidogrel. 
Materials and Methods 
Forty patients were selected among acute ischemic 
admissions during the study period in Razi University 
Hospital, Tabriz, Iran. The subjects who were enrolled in this 
study had clinical features compatible with a stroke in MCA 
territory such as hemiparesis that affects the face and upper 
limb more than the lower limb, homonymous hemianopia, 
hemianesthesia, aphasia if the dominant hemisphere is 
involved and hemineglect agraphesthesia and astereognosis 
with non-dominant hemisphere lesions [1]. 
All patients underwent a full clinical and diagnostic work 
up, including evaluation of cerebrovascular risk factors, 
laboratory tests and brain computed tomography (CT) 
imaging. Carotid stenosis was assessed by a radiologist with 
color Doppler scanning (ALOKA ProSound 3500, Japan) 
with 7.5-MHz frequency. Cardiac disease was diagnosed by a 
cardiologist on the basis of clinical examination, 
electrocardiography and transthoracic echocardiography. 
Those patients with the potential source of cardioembolism 
such as atrial fibrillation, mechanical heart value, and 
pacemaker were excluded. Brain CT scan was performed in 
all patients to rule out previous subclinical infarcts and 
intracranial hemorrhage. In this study patients with clinical 
symptoms of lacunar ischemic stroke, watershed infarct, 
multiple infarcts, bihemispheric infarcts and a history of 
previous stroke were excluded, as well. In addition, patients 
in an agitated or confused state, unable to endure the duration 
of TCD monitoring were excluded. 
Eligible participants were randomized in to two groups 
treated with aspirin 80 mg or clopidogrel 75mg daily. TCD 
monitoring was performed between day 3 and 7 after onset 
of stroke symptoms, to detected MES in both middle 
cerebral arteries. The TCD method and MES identification 
was performed in accordance with the criteria established 
by International Consensus Group on Microembolus 
Detection [10]. 
In this study a 2-MHz pulse-wave transcranial Doppler 
device (Looki-9Tc Atys Medical-France) was used for one 
hour insonation of both middle cerebral arteries in depth of 
45 and 55mm multigate. The signal intensity measurement 
algorithm used the whole screen as background. A 64-point 
fast Fourier transformation and bigate technique was used. A 
detection threshold of 9dB was used. All sonic signals 
automatically saved on computer hard disk and were 
analyzed by an experienced observer who was blinded to 
the clinical and laboratory data. 
A check list was designed to collect the demographic 
characteristics of the participants. The data included ago, 
sex, relevant medical risk factors diabetes mellitus (DM), 
Hypertension (HTN), hyperlipidemia (HLP), ischemic 
heart disease (IHD) and previous aspirin consumption. All 
participants signed an informed consent after receiving 
required information regarding the study. No additional 
expenses were imposed by doing this study on the patients, 
except for the standard of the care provided for every other 
patient with similar conditions. This study was approved 
by the local ethics committee of Tabriz University of 
Medical Sciences.  
The results were analyzed through descriptive 
statistical methods, 2-chi square relation, mean, 
independent, Mann-Whitney u-test, samples t-test using 
SPSS 15 statistical software. Logistic regression was used 
to assessing risk factors. P-values less than 0.05 were 
considered as significant. 
Results 
Forty patients were enrolled in the study and randomized 
into two groups from the first day of admission 20 of them 
underwent treatment with aspirin (80mg daily) and others 
clopidogrel (75mg daily). Summary of the patients' 
characteristics in each therapeutic group is shown in table 
1. Comparing aspirin group with clopidogrel group in 
regard to sex, age, HTN, DM, HLP, and IHD showed no 
statistically significant difference. 
In all patients, electrocardiogram showed sinus rhythm 
and transthoracic echocardiography did not demonstrate 
any cardioembolic source. Frequency of carotid arteries 
stenosis in each therapeutic group is shown in table 2. 
The mean interval time between onset of symptoms 
and TCD were 6.10±0.99 and 5.50±13.0 in aspirin and 
clopidogrel groups, respectively (P-value= 0.037). In 6 
(30%) patients of aspirin group, MES were detected 
Among them, 2 (33.3%) had carotid stenosis less than 
10% and 4 (66.6%) between 10% to 50%. Four (20%) 
patients of clopidogrel group were identified with 
microembolic signals; 1 of 4 patients (25%) had less than 
10%, 2 (50%) between 10% to 50% and 1 (25%) more 
than 50% carotid stenosis. The comparison between two 
groups regarding detection of MES was not statistically 
significant (P-value= 0.46).  
 
Table 1. Summary of the patients' characteristics in each therapeutic group 
 Gender 
Male  
Mean Age HTN DM HLP IHD Previously Aspirin 
taking 
Aspirin 7(35%)  68.95±13.55 16(80%) 3(15%) 4(20%) 1(5%) 2(10%) 
Clopidogrel 12(60%) 66.10±12.17 12(60%) 8(40%) 6(30%) 7(35%) 4(20%) 
 
  





Table 2. Frequency of carotid arteries stenosis in each 
therapeutic group 
 
Degree of Carotid stenosis 
 
<10% 10% to 50% 50%< Total 
Aspirin 8 4 1 13 
Clopidogrel 6 5 1 12 
Discussion 
Considering the fact that the majority of carotid emboli 
anatomically enter into MCA, we studied patients with 
ischemic stroke in MCA territories. Moreover, previous 
studies showed the higher prevalence of MES in patients 
with large-vessel atherosclerosis than in those with 
cardioembolic strokes, TIA or small-vessel disease [11,12]. 
In our study, MES was detected in 30% of patients treated 
with aspirin and 20% of those treated with clopidogrel. 
However, the comparison showed no significant difference. 
In addition, there were no statistically meaningful differences 
regarding carotid stenosis prevalence between two groups. As 
a result, our study found no difference in efficacy of each 
drug in decreasing MES. 
The efficacy of aspirin versus clopidogrel in reducing 
the MES rate was not evaluated in previous studies. 
However, the efficacy of dual antiplatelet therapy versus 
aspirin was noticed in some of them. One of major trials, 
CARESS [13], showed combination therapy of aspirin and 
clopidogrel in reducing the MES rate in patients with 
symptomatic carotid stenosis were more effective than 
aspirin alone. These results are consistent with those from  
CLAIR study [14]. A recent published study evaluated the 
efficacy of clopidogrel versus dipyridamole in addition to 
aspirin in reducing embolization. They included sixty 
patients with recent symptomatic carotid stenosis, thirty in 
each group. Ambulatory transcranial Doppler were 
performed at baseline and after 48 hours. In patients with 
embolic signals at baseline, there was no difference in 
reduction in embolic signal frequency. The presence of 
MES in significant percent of our patients were in 
accordance with other studies [11,16]. However, absence of 
significant carotid arteries stenosis was in contrast to the 
findings of Marcus [17]. 
Regarding the lower cost of aspirin and no significant 
difference between the efficacy of aspirin and clopidogrel in 
decreasing the MES rate, our study suggested aspirin as a 
possible choice versus clopidogrel. Also in keeping with 
previous studies, we found transcranial Doppler as a 
possible beneficial and noninvasive diagnostic tool in 
detecting MES. Further studies with larger sample size and 
performing TCD at baseline for detecting MES are 
recommended in more confirmation of this study. 
Acknowledgement 
We would like to thank and appreciate the staff and 
assistants of the neurology ward of Razi Hospital, Tabriz, 
Iran and the patients who participated in our study. 
This article was written based on a dataset of MD thesis, 
registered in Tabriz University of Medical Sciences, Tabriz, 
Iran. 
References 
1. Biller j., Love B.B., Schneck M.J. Vascular 
diseases of the nervous system: Bradly W.G., 
Daroff R.B., Jankovic J. [ed.]. Neurology in 
clinical practice. Ed. 5. Elsevier Philadelphia 
2008, pp. 1165-1214. 
2. Lopez AD, Mathers SD, Ezzati M, Jamison 
DT, Murray CJ. Global and Regional burden 
of disease and risk factors, 2001 systemic 
analysis of population health data. Lancet 
2006; 367:1744-57. 
3. Rothwell PM, Buchan A, Johnston SC. 
Recent advances in management of transient 
ischemic attacks and minor ischemic strokes. 
Lancet Neurol 2006; 53:23-331. 
4. Ovbiagele B, Cruz-Flores S, Lynn MJ, et al. 
Early stroke risk after transient intracranial 
artery stenosis. Arch Neurol 2008; 65:733-7. 
5. Wong KS, Li H, Chan YL, et al. Use of 
transcranial Doppler to predict outcome in 
patients with intracranial large artery 
occlusive disease. Stroke 2000; 31:2641-7. 
6. Siebler M, Sitzer M, Rose G, et al. Cerebral 
microembolism and the risk of ischemia in a 
symptomatic high grade internal carotid a 
rtery stenosis. Stroke 1995; 26: :2184-6. 
7. Iguchi Y, Kimura K, Kobayashi K, et al. 
Microembolic signals at 48 hours after stroke 
onset contribute to new ischemia within a 
week. J Neurol Neurosurg Psychiatry 2008; 
79:253-9. 
8. Wong KS, Gao S, Chan YL, et al. 
Mechanisms of acute cerebral infarctions in 
patients with middle cerebral artery stenosis: 
a diffusion-weighted imaging and 
microemboli monitoring study. Ann Neurol 
2002; 5:74-81. 
9. Gao S, Wong KS, Hansberg T, et al. 
Microembolic signals Predicts recurrent 
cerebral ischemic events in acute stroke 
patients with middle cerebral artery stenosis. 
Stroke 2004; 35:2832-6. 
10. Ringelstein EB, Droste DW, Babikian VL, et 
al. Consensus on microembolus detection by 
TCD. International Consensus Group on 
Microembolus Detection. Stroke 1998; 
29:725-9. 
11. Sarasin FP, Louis-Simonet M, Carballo D, et 
al. Prospective evaluation of patients with 
syncope: a population-based study. Am J 
Med 2001; 111:177-84. 
12. Serena J, Segura T, Castellanos M, et al. 
Microembolic signal monitoring in 
hemispheric acute ischaemic stroke: a 
prospective study. Cerebrovasc Dis 2000; 
10:278-82. 
13. Markus HS, Droste DW, Kaps M, et al. Dual 
antiplatelet therapy with clopidogrel and 
aspirin in symptomatic carotid stenosis 
evaluated using doppler embolic signal 
detection: the Clopidogrel and Aspirin for 
Reduction of Emboli in Symptomatic Carotid 
Stenosis (CARESS) trial. Circulation 2005; 
111, 2233-40. 
14. Zhao Y, Koh A, Hao Q, et al. Clopidogrel 
plus aspirin versus aspirin alone for reducing 
embolisation in patients with acute 
symptomatic cerebral or carotid artery 
stenosis (CLAIR study): a randomised, open-
label, blinded-endpoint trial. Lancet Neurol 
2010; 9:489-97. 
15. King A, Bath PM, Markus HS. Clopidogrel 
versus dipyridamole in addition to aspirin in 
reducing embolization detected with 
ambulatory transcranial Doppler: a 
randomized trial. Stroke 2011; 42:650-5. 
16. Segura T, Serena J, Castellanos M, et al. 
Embolism in acute middle cerebral artery 
stenosis. Neurology 2001; 56:497-501. 
17. Markus HS, MacKinnon A. Asymptomatic 
embolization detected by Doppler ultrasound 
predicts stroke risk in symptomatic carotid 
artery stenosis. Stroke 2005; 971-5.
 
